Current and potential use of GLP-1R agonists: beyond type 2 diabetes

Current and potential use of GLP-1R agonists: beyond type 2 diabetes

Graciela Zambrano-Galván 1, Ángel González-Romero 2, Miguel A. Reyes-Romero 3, Abelardo Camacho-Luis 4

1 Faculty of Medicine and Nutrition, Nutriepigenomics and Clinical Nutrition Laboratory, Food and Nutrition Research Center, Universidad Juárez del Estado de Durango, Durango, Mexico; 2 Faculty of Medicine and Nutrition, Internal Medicine Service, Universidad Juárez del Estado de Durango, Durango, Mexico; 3 Faculty of Medicine and Nutrition, Molecular Medicine Laboratory, Food and Nutrition Research Center, Universidad Juárez del Estado de Durango, Durango, Mexico; 4 Faculty of Medicine and Nutrition, Nutritional Physiology Laboratory, Food and Nutrition Research Center. Universidad Juárez del Estado de Durango, Durango, Mexico

Graciela Zambrano-Galván, Ángel González-Romero, Miguel A. Reyes-Romero, Abelardo Camacho-Luis

La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.

*Correspondence: Abelardo Camacho-Luis, Email not available

Summary

Keywords:  Glucagon-like peptide 1 receptor. Incretins. Pharmacological glucagon-like peptide 1 receptor agonists. Type 2 diabetes.

Contents

DOI: 10.24875/RME.23000053
Add to Mendeley
    Descargar PDF
    English versión
    DOI: 10.24875/RME.23000053